Search Results
Results found for "Eunice S Wang"
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
Proc Natl Acad Sci U S A, 2012. 109 (45): p. 18607-12. 8.
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
It ’s a screening tool, not a substitute for rigorous Schild validation.
- Understanding Enzyme Inhibition In GPCR Discovery Programs
If you want your molecules to survive first contact with biology, enzyme inhibition must be part of your This spotlight from Montana Molecular dives into how OPN3’s modulation of MCR4 in appetite circuits and It’s built for scientists and teams who want fewer tabs and faster decisions—one scroll that blends structure
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
Biomed Pharmacother. 2018 Feb;98:222-232. doi: 10.1016/j.biopha.2017.12.056 Azam S, Haque ME, Jakaria
- 📰 GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!
GPCR University offers two live courses this fall that you won’t want to miss. s Check out the details of each course below: Open to the Public: Enrollment is Now Available!
- 📰 GPCR Weekly News, February 13 to 19, 2023
In Anesthesiology Neurocrine Biosciences discovers new muscarinic M4 receptor antagonists Alexander S.
- Chemokine receptor-targeted drug discovery: progress and challenges
The chemokine receptor system is implicated in a wide range of inflammatory, autoimmune and infectious binding, as well as G-protein coupling or interaction with other signaling molecules (Sohy et al. 2009; Wang protein-protein interactions which are difficult to modulate using small molecules (Sohy et al. 2009; Wang
- 📰 GPCR Weekly News, November 6 to November 12, 2023
and cross-reactivity in tachykinin NK1 and NK2 receptors GPCR Binders, Drugs, and more Discovery of (S)
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
J., & Fields, S. (2014).
- 📰 GPCR Weekly News, November 13 to 19, 2023
receptor negatively modulates substance P responses by forming complex with Neurokinin-1 receptor NTR-1's
- Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024
Natural Products and Compounds: Potential Therapeutic Targets for the Treatment of Neurological Disease s
- Therapeutic validation of an orphan G protein‐coupled receptor
Regarding the first question, GPR84 overexpression in immune cells in a range of pro‐inflammatory disorders indole‐3‐carbinol, which is present at high levels in some vegetables including broccoli and kale (Wang
- Ode to GPCRs
S. of. S. Non-traditional roles of G protein-coupled receptors in basic cell biology.
- Profiling Immune Cell and Platelet Transcriptomes
The study reports that human white blood cells express an average of 160 GPCR mRNAs, ranging from 123 the insights gained from this research will be instrumental in shaping therapeutic strategies for a range
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
to predict subtype-selective ligands for dopamine receptors and adenosine receptors (He, Ben, Kuang, Wang & Kong, 2016; Kuang, Feng, Hu, Wang, He & Kong, 2016). 5.
- Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84
August 2022 "Despite the importance of members of the GPCR superfamily as targets of a broad range of Expression of GPR84 is strongly up regulated in immune cells in a range of pro-inflammatory settings
- Discovery On Target, October 17-20, 2022, Boston, USA
well as target validation strategies for the discovery and development of novel therapeutic agents ranging
- ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to Expand Pipeline and Partnerships
clinical-stage global biopharmaceutical company developing novel oral therapeutics to treat a wide range
- Obesity-induced changes in human islet G protein-coupled receptor expression: Implications for ...
this review, we have compared expression of GPCR mRNAs in human islets obtained from normal weight range donors, and those with a weight range classified as obese.
- Crinetics Pharmaceuticals announced the formation of an independently operated new company...
develop a deep pipeline of novel, targeted, nonpeptide radiopharmaceuticals for the treatment of a broad range develop a deep pipeline of novel, targeted, nonpeptide radiopharmaceuticals for the treatment of a broad range
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
Upcoming events: “Drug Discovery at Superluminal Speeds”; and Discovery on Target 2025—GPCR track you’ll want lesson shows how to replace inference with models that disentangle mechanism—so your next go/no-go, dose range Engineer assays on purpose: Set ranges, controls, and system sensitivity to surface mechanism—before It’s built for scientists and leaders who want the signal, not the scroll: frameworks that clarify mechanism
- MSX-122: Is an effective small molecule CXCR4 antagonist in cancer therapy?
cytokines along with their receptors, are involved in various biologic processes and regulation of a wide range
- The Quiet Power of RGS Proteins: Rethinking Pain Pathways through GPCR Biology
interesting phenotype the lab found where, as a mouse was starting to enter what we consider the chronic pain range
- G protein-coupled receptor signaling: transducers and effectors
"G protein-coupled receptors (GPCRs) are of considerable interest due to their importance in a wide range
- Verily links up with Sosei Heptares for GPCR drug discovery
recent years as researchers have discovered the vast potential for GPCR-targeting drugs in treating a range
- G protein-coupled receptor kinase type 2 and β-arrestin2: Key players in immune cell functions...
GRK2/β-arrestin2 play multiple roles in the pathological mechanisms of a wide range of diseases including
- Cancer Research UK and Sosei Heptares sign agreement to advance cancer immunotherapy candidate ...
candidate into clinical trials "HTL0039732 is a novel EP4 antagonist with potential to treat a wide range
- Dr. GPCR and Eurofins DiscoverX Join Forces to Accelerate GPCR Drug Discovery
Their cell-based assays support a wide range of mechanisms of action, including cAMP accumulation, β-arrestin
- AlphaFold2 versus experimental structures: evaluation on G protein-coupled receptors
August 2022 "As important drug targets, G protein-coupled receptors (GPCRs) play pivotal roles in a wide range
- Advantages of Fluorescent Probes in GPCR Assays
This happens when prolonged exposure to light in the excitation range causes the emission signal to decrease wavelengths, where fluorescence from the cell components is minimal, as well as expanding the working range










